Clinical Trial Update: High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating high-dose melphalan with total-body irradiation followed by peripheral stem cell transplantation for patients with multiple myeloma i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: Mayo Clinic | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED